<ul>
<li>最近几周，Merit Medical Systems 面临华尔街观点的转变，富国银行下调了其评级，尽管没有重大运营变化，但导致了一段时间的持续机构抛售。</li>
<li>值得注意的是，该公司的基础运营和财务健康状况依然稳健，这表明投资者情绪的变化超过了商业基本面的变化。</li>
<li>我们将探讨富国银行的下调及随之而来的情绪变化可能如何影响 Merit Medical Systems 现有的投资叙事。</li>
</ul>
<p>寻找 48 家现金流潜力良好但交易价格低于其公允价值的公司。</p>
<h2>Merit Medical Systems 投资叙事回顾</h2>
<p>要拥有 Merit Medical Systems，您需要相信微创手术的长期采用以及公司在创新和收购方面的增长能力，尽管面临报销和成本压力。富国银行的下调和近期股价疲软主要影响情绪，而不是围绕 WRAPSODY 报销进展的核心短期催化剂，同时现有风险如中国市场暴露和上升的运营费用对业务本身仍然更为相关。</p>
<p>最近的 2025 年第四季度和全年业绩显示收入和盈利持续增长，2026 年的指引指向进一步的收入扩张，这有助于将富国银行的下调置于仍在增长的运营背景下。对于投资者来说，这种市场情绪的软化与持续的业务执行之间的对比可能会加深对当前定价是否已经反映已知风险（如 WRAPSODY 门诊报销延迟和更高的增长支出）的关注。</p>
<p>然而，尽管情绪可能迅速波动，但 WRAPSODY 的报销延迟及其对短期增长的影响是投资者应当关注的...</p>
<p>阅读关于 Merit Medical Systems 的完整叙事（免费！）</p>
<p>Merit Medical Systems 的叙事预计到 2028 年收入将达到 18 亿美元，盈利为 1.972 亿美元。这需要每年 7.0% 的收入增长，以及约 7800 万美元的盈利增长，从今天的 1.191 亿美元增加。</p>
<p>揭示 Merit Medical Systems 的预测如何得出 103.55 美元的公允价值，相较于当前价格有 48% 的上涨空间。</p>
<h2>探索其他观点</h2>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/efec4751-e8fa-4c0d-9366-5661edf64033/chart/quote-price?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/efec4751-e8fa-4c0d-9366-5661edf64033/chart/quote-price"/></p>
<p>MMSI 1 年股票价格走势图</p>
<p>Simply Wall St 社区的两位成员目前认为 Merit Medical Systems 的公允价值在 81.94 美元至 103.55 美元之间，突显了观点的差异。在最近的下调驱动的情绪变化背景下，这种观点的差异邀请您通过几种对比的视角权衡 WRAPSODY 的报销延迟和其他公司特定风险。</p>
<p>探索关于 Merit Medical Systems 的另外 2 个公允价值估算 - 为什么该股票可能比当前价格高出 48%！</p>
<h2>得出您自己的结论</h2>
<p>不要仅仅跟随股票代码 - 深入数据，建立真正属于您自己的信念。</p>
<ul>
<li>开始研究 Merit Medical Systems 的一个好起点是我们的分析，强调可能影响您投资决策的 4 个关键回报。</li>
<li>我们的免费 Merit Medical Systems 研究报告提供了全面的基本面分析，汇总在一个视觉图中 - 雪花图，使您能够一目了然地评估 Merit Medical Systems 的整体财务健康状况。</li>
</ul>
<h2>考虑其他策略？</h2>
<p>现在可能是最佳入场时机。这些推荐来自我们每日扫描的最新信息。不要拖延：</p>
<ul>
<li>探索 23 家领先下一代技术革命的量子计算公司，推动量子算法、超导量子比特和前沿研究的突破。</li>
<li>我们发现了 14 家股息堡垒，收益率超过 5%，不仅能在市场风暴中生存，还能在其中蓬勃发展。</li>
<li>工作的未来已经到来。发现 30 家领先 AI 驱动自动化和工业转型的机器人和自动化股票。</li>
</ul>
<p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章并不构成财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也不考虑您的目标或财务状况。我们旨在为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
<h3><strong>新功能：在一个地方管理您的所有股票投资组合</strong></h3>
<p>我们为股票投资者创建了 <strong>终极投资组合助手</strong>，<strong>而且是免费的。</strong></p>
<p>• 连接无限数量的投资组合，并以一种货币查看您的总额</p>
<p>• 通过电子邮件或手机接收新的警告信号或风险提示</p>
<p>• 跟踪您股票的公允价值</p>
<p>免费试用演示投资组合</p>

Merit医疗系统

富国银行

<p>Merit 医疗系统遭到富国银行的评级下调，尽管运营稳定，但导致机构抛售。此次评级下调对市场情绪的影响大于公司的基本面，后者显示出持续的收入和盈利增长。公司预计到 2028 年收入将达到 18 亿美元，盈利为 1.972 亿美元，表明其当前价格有潜在 48% 的上涨空间。投资者在评估该股票的公允价值时，建议考虑 WRAPSODY 报销延迟和其他风险，公允价值范围在 81.94 美元至 103.55 美元之间</p>

<ul>
<li>In recent weeks, Merit Medical Systems faced a shift in Wall Street opinion when Wells Fargo downgraded its rating, prompting a period of sustained institutional selling despite no major operational changes.</li>
<li>What stands out is that the company’s underlying operations and financial health remain solid, suggesting investor sentiment has moved more than the business fundamentals.</li>
<li>We’ll now explore how Wells Fargo’s downgrade and the resulting sentiment shift may influence Merit Medical Systems’ existing investment narrative.</li>
</ul>
<div class="lb-trans"><ul>
<li>最近几周，Merit Medical Systems 面临华尔街观点的转变，富国银行下调了其评级，尽管没有重大运营变化，但导致了一段时间的持续机构抛售。</li>
<li>值得注意的是，该公司的基础运营和财务健康状况依然稳健，这表明投资者情绪的变化超过了商业基本面的变化。</li>
<li>我们将探讨富国银行的下调及随之而来的情绪变化可能如何影响 Merit Medical Systems 现有的投资叙事。</li>
</ul>
</div><p>Find 48 companies with promising cash flow potential yet trading below their fair value.</p>
<div class="lb-trans"><p>寻找 48 家现金流潜力良好但交易价格低于其公允价值的公司。</p>
</div><h2>Merit Medical Systems Investment Narrative Recap</h2>
<div class="lb-trans"><h2>Merit Medical Systems 投资叙事回顾</h2>
</div><p>To own Merit Medical Systems, you need to believe in the long term adoption of minimally invasive procedures and the company’s ability to grow through innovation and acquisitions, despite reimbursement and cost pressures. Wells Fargo’s downgrade and the recent share price weakness mainly affect sentiment rather than the core near term catalyst around WRAPSODY reimbursement progress, while existing risks such as China exposure and rising operating expenses remain more relevant to the business itself.</p>
<div class="lb-trans"><p>要拥有 Merit Medical Systems，您需要相信微创手术的长期采用以及公司在创新和收购方面的增长能力，尽管面临报销和成本压力。富国银行的下调和近期股价疲软主要影响情绪，而不是围绕 WRAPSODY 报销进展的核心短期催化剂，同时现有风险如中国市场暴露和上升的运营费用对业务本身仍然更为相关。</p>
</div><p>The most recent Q4 2025 and full year 2025 results showed continued revenue and earnings growth, with 2026 guidance pointing to further top line expansion, which helps frame the Wells Fargo downgrade against a backdrop of still growing operations. For investors, this contrast between softer market sentiment and ongoing business execution may sharpen the focus on whether current pricing already reflects known risks like delayed WRAPSODY outpatient reimbursement and higher spending on growth.</p>
<div class="lb-trans"><p>最近的 2025 年第四季度和全年业绩显示收入和盈利持续增长，2026 年的指引指向进一步的收入扩张，这有助于将富国银行的下调置于仍在增长的运营背景下。对于投资者来说，这种市场情绪的软化与持续的业务执行之间的对比可能会加深对当前定价是否已经反映已知风险（如 WRAPSODY 门诊报销延迟和更高的增长支出）的关注。</p>
</div><p>Yet while sentiment may swing quickly, the reimbursement delay for WRAPSODY and its impact on near term growth is something investors should be aware of...</p>
<div class="lb-trans"><p>然而，尽管情绪可能迅速波动，但 WRAPSODY 的报销延迟及其对短期增长的影响是投资者应当关注的...</p>
</div><p>Read the full narrative on Merit Medical Systems (it's free!)</p>
<div class="lb-trans"><p>阅读关于 Merit Medical Systems 的完整叙事（免费！）</p>
</div><p>Merit Medical Systems' narrative projects $1.8 billion revenue and $197.2 million earnings by 2028. This requires 7.0% yearly revenue growth and about a $78 million earnings increase from $119.1 million today.</p>
<div class="lb-trans"><p>Merit Medical Systems 的叙事预计到 2028 年收入将达到 18 亿美元，盈利为 1.972 亿美元。这需要每年 7.0% 的收入增长，以及约 7800 万美元的盈利增长，从今天的 1.191 亿美元增加。</p>
</div><p>Uncover how Merit Medical Systems' forecasts yield a $103.55 fair value, a 48% upside to its current price.</p>
<div class="lb-trans"><p>揭示 Merit Medical Systems 的预测如何得出 103.55 美元的公允价值，相较于当前价格有 48% 的上涨空间。</p>
</div><h2>Exploring Other Perspectives</h2>
<div class="lb-trans"><h2>探索其他观点</h2>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/efec4751-e8fa-4c0d-9366-5661edf64033/chart/quote-price" alt="" original-src="https://images.simplywall.st/company/efec4751-e8fa-4c0d-9366-5661edf64033/chart/quote-price"/></p>
<p>MMSI 1-Year Stock Price Chart</p>
<div class="lb-trans"><p>MMSI 1 年股票价格走势图</p>
</div><p>Two members of the Simply Wall St Community currently see fair value for Merit Medical Systems between US$81.94 and US$103.55, underscoring how far opinions can stretch. Set against the recent downgrade driven sentiment shift, this spread in views invites you to weigh WRAPSODY’s reimbursement delays and other firm specific risks through several contrasting lenses.</p>
<div class="lb-trans"><p>Simply Wall St 社区的两位成员目前认为 Merit Medical Systems 的公允价值在 81.94 美元至 103.55 美元之间，突显了观点的差异。在最近的下调驱动的情绪变化背景下，这种观点的差异邀请您通过几种对比的视角权衡 WRAPSODY 的报销延迟和其他公司特定风险。</p>
</div><p>Explore 2 other fair value estimates on Merit Medical Systems - why the stock might be worth as much as 48% more than the current price!</p>
<div class="lb-trans"><p>探索关于 Merit Medical Systems 的另外 2 个公允价值估算 - 为什么该股票可能比当前价格高出 48%！</p>
</div><h2>Reach Your Own Conclusion</h2>
<div class="lb-trans"><h2>得出您自己的结论</h2>
</div><p>Don't just follow the ticker - dig into the data and build a conviction that's truly your own.</p>
<div class="lb-trans"><p>不要仅仅跟随股票代码 - 深入数据，建立真正属于您自己的信念。</p>
</div><ul>
<li>A great starting point for your Merit Medical Systems research is our analysis highlighting 4 key rewards that could impact your investment decision.</li>
<li>Our free Merit Medical Systems research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Merit Medical Systems' overall financial health at a glance.</li>
</ul>
<div class="lb-trans"><ul>
<li>开始研究 Merit Medical Systems 的一个好起点是我们的分析，强调可能影响您投资决策的 4 个关键回报。</li>
<li>我们的免费 Merit Medical Systems 研究报告提供了全面的基本面分析，汇总在一个视觉图中 - 雪花图，使您能够一目了然地评估 Merit Medical Systems 的整体财务健康状况。</li>
</ul>
</div><h2>Contemplating Other Strategies?</h2>
<div class="lb-trans"><h2>考虑其他策略？</h2>
</div><p>Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:</p>
<div class="lb-trans"><p>现在可能是最佳入场时机。这些推荐来自我们每日扫描的最新信息。不要拖延：</p>
</div><ul>
<li>Explore 23 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.</li>
<li>We've uncovered the 14 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.</li>
<li>The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.</li>
</ul>
<div class="lb-trans"><ul>
<li>探索 23 家领先下一代技术革命的量子计算公司，推动量子算法、超导量子比特和前沿研究的突破。</li>
<li>我们发现了 14 家股息堡垒，收益率超过 5%，不仅能在市场风暴中生存，还能在其中蓬勃发展。</li>
<li>工作的未来已经到来。发现 30 家领先 AI 驱动自动化和工业转型的机器人和自动化股票。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章并不构成财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也不考虑您的目标或财务状况。我们旨在为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div><h3><strong>New:</strong> Manage All Your Stock Portfolios in One Place</h3>
<div class="lb-trans"><h3><strong>新功能：在一个地方管理您的所有股票投资组合</strong></h3>
</div><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p>
<div class="lb-trans"><p>我们为股票投资者创建了 <strong>终极投资组合助手</strong>，<strong>而且是免费的。</strong></p>
</div><p>• Connect an unlimited number of Portfolios and see your total in one currency</p>
<div class="lb-trans"><p>• 连接无限数量的投资组合，并以一种货币查看您的总额</p>
</div><p>• Be alerted to new Warning Signs or Risks via email or mobile</p>
<div class="lb-trans"><p>• 通过电子邮件或手机接收新的警告信号或风险提示</p>
</div><p>• Track the Fair Value of your stocks</p>
<div class="lb-trans"><p>• 跟踪您股票的公允价值</p>
</div><p>Try a Demo Portfolio for Free</p>
<div class="lb-trans"><p>免费试用演示投资组合</p>
</div>

富国银行的降级和抛售浪潮会改变 Merit 医疗系统（MMSI）的市场叙述吗？